{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "31722-001",
      "generic_name": "lamivudine",
      "labeler_name": "Camber Pharmaceuticals, Inc.",
      "brand_name": "lamivudine",
      "active_ingredients": [
        {
          "name": "LAMIVUDINE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "31722-001-02",
          "description": "20 BLISTER PACK in 1 CARTON (31722-001-02)  / 10 TABLET, FILM COATED in 1 BLISTER PACK",
          "marketing_start_date": "20190321",
          "sample": false
        },
        {
          "package_ndc": "31722-001-60",
          "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-001-60)",
          "marketing_start_date": "20190321",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Camber Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "205328"
        ],
        "spl_set_id": [
          "e90671c6-7fff-48f4-8898-29f02d049c8b"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0331722001601"
        ],
        "nui": [
          "N0000175656",
          "N0000175462",
          "N0000009947"
        ],
        "pharm_class_epc": [
          "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
          "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "unii": [
          "2T8Q726O95"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "2b449c4a-56db-0d5f-e063-6394a90ad576",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190321",
      "product_id": "31722-001_2b449c4a-56db-0d5f-e063-6394a90ad576",
      "application_number": "ANDA211306",
      "brand_name_base": "lamivudine",
      "pharm_class": [
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
      ]
    }
  ]
}